/Companies

Akadeum Life Sciences

Ann Arbor, US · Founded 2014 · Delaware corporation · 14 employees on LinkedIn · 14 known investors

Find your way into Akadeum Life Sciences

2 people in our graph can introduce you to the Akadeum Life Sciences team.

Sign up to see every warm intro you have to Akadeum Life Sciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Akadeum Life Sciences team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.

Founders & leadership

Akadeum Life Sciences was founded in 2014 by Kalyan Handique and John Younger.

KH
Kalyan HandiqueCo-founder
JYJohn Younger
John YoungerCo-founderHe previously held NIH- and NSF-funded faculty positions at the University of Michigan, served on the National Advisory General Medical Sciences Council, and directed technology transfer investment portfolios at the University City Science Center in Philadelphia.
JM
James MilitelloExecutive

Board

JS
Jeffrey S. WilliamsBoard director
PDPaul D'Amato
Paul D'AmatoBoard directorCEO & Founding Partner at Michigan Capital Network
DKDan Kidle
Dan KidleBoard MemberManaging Partner at Arboretum Ventures
BMBrandon McNaughton
Brandon McNaughtonChief Executive Officer and Co-FounderA physicist and inventor, he co-founded Akadeum in 2014 after founding Life Magnetics, where he served as CTO, and holding innovator- and inventor-in-residence roles at the University of Michigan's Venture Center and Health System. He was previously an assistant research scientist in biomedical engineering at Michigan, an entrepreneur in residence with Detroit Innovate at Invest Detroit, and an entrepreneurship practicum instructor at the University of Michigan Center for Entrepreneurship.
JLJenni Li
Jenni LiBoard directorSenior Principal at Michigan Capital Network
DNDouglas Neal
Douglas NealBoard Observer2014–2025Managing Director at eLab Ventures

Investors · 14

Reported raises · per SEC filings

Form D private placements

$17.6M disclosed across 8 rounds · 2014–2026

▶$2.1MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalyan HandiqueExecutive Officer, Director
  • Paul D'AmatoDirector
  • Jenni LiDirector
  • James MilitelloExecutive Officer
Offering amount
$3.4M
Amount sold
$2.1M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.6MraisedApr 2025 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey S. WilliamsDirector
  • Paul D'AmatoDirector
  • Dan KidleDirector
  • Brandon McNaughtonExecutive Officer, Director
  • James MilitelloExecutive Officer
Offering amount
$7.2M
Amount sold
$5.6M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HyunDirector
  • Brandon McNaughtonExecutive Officer, Director
  • Dan KidleDirector
  • George DunbarDirector
  • John GavenonisDirector
Offering amount
$6.5M
Amount sold
$6M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$900KraisedNov 2018 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • John YoungerExecutive Officer, Director
  • Brock SiegelDirector
  • Douglas NealDirector
Offering amount
$2M
Amount sold
$900K
Minimum investment
$25K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedAug 2017 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BrownDirector
  • John YoungerExecutive Officer, Director
  • Brandon McNaughtonExecutive Officer, Director
  • William WoodDirector
  • Douglas NealDirector
Offering amount
$1.6M
Amount sold
$1.5M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$360KraisedDec 2016 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John YoungerExecutive Officer, Director
  • Douglas NealDirector
  • Brandon McNaughtonExecutive Officer, Director
Offering amount
$1M
Amount sold
$360K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$905.1KraisedAug 2015 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • Douglas NealDirector
  • John YoungerExecutive Officer, Director
Offering amount
$1M
Amount sold
$905.1K
First sale
May 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedOct 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John YoungerExecutive Officer, Director
  • Brandon McNaughtonExecutive Officer, Director
Offering amount
$150K
Amount sold
$150K
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Akadeum Life Sciences.

In the news

Frequently asked questions

What does Akadeum Life Sciences do?
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Who founded Akadeum Life Sciences?
Akadeum Life Sciences was founded by Kalyan Handique, John Younger in 2014.
Who are Akadeum Life Sciences's investors?
Akadeum Life Sciences's investors include Arboretum Ventures, Beringea, Berkeley Catalyst, BlueStone Venture Partners, CANTILEVER INVESTORS, eLab Ventures, Hemisphere Ventures LLC, ID Ventures and 6 more.
How much funding has Akadeum Life Sciences raised?
Akadeum Life Sciences has disclosed $17.6M raised across 8 rounds.
Where is Akadeum Life Sciences headquartered?
Akadeum Life Sciences is headquartered in Ann Arbor, US.